Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Third party research

Scanfil: End demand remains volatile - Nordea

Scanfil

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
Scanfil's Q2 net sales and clean EBIT were slightly below LSEG Data & Analytics consensus. Full-year guidance was repeated, despite market volatility. Because visibility has not greatly improved, we expect market consensus EBIT to decline by EUR 1m (2%) for 2024 after the earnings release. We believe end demand could remain modest for Industrial and Energy applications in Q3 2024. However, Q2 net sales already grew in the Medtec & Life Science segment on a q/q basis. Our fair value range remains at EUR 7.7-9.5, based on three equally weighted valuation approaches (DCF, EV/EBITDA and P/E). Marketing material commissioned by Scanfil Oyj.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.